According to the above fact of the laboratory results, this compound can be proposed as a lead structure for the design and synthesis of more potent P-glycoprotein inhibitors for combination used with anti-cancer drugs for cancer multidrug resistance management. The gene discussed is ABCB1; the disease is cancer.